These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36672339)

  • 41. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
    Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T
    Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoprotein.
    Hamamura K; Shiratori Y; Shiina S; Imamura M; Obi S; Sato S; Yoshida H; Omata M
    Cancer; 2000 Apr; 88(7):1557-64. PubMed ID: 10738213
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma.
    Shindoh J; Sugawara Y; Nagata R; Kaneko J; Tamura S; Aoki T; Sakamoto Y; Hasegawa K; Tanaka T; Kokudo N
    Transpl Int; 2014 Apr; 27(4):391-8. PubMed ID: 24472068
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma.
    Liu C; Xiao GQ; Yan LN; Li B; Jiang L; Wen TF; Wang WT; Xu MQ; Yang JY
    World J Gastroenterol; 2013 Mar; 19(11):1811-9. PubMed ID: 23555170
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Frequency of elevated biomarkers in patients with cryptogenic hepatocellular carcinoma.
    Taura N; Ichikawa T; Miyaaki H; Ozawa E; Tsutsumi T; Tsuruta S; Kato Y; Goto T; Kinoshita N; Fukushima M; Kato H; Ohata K; Ohba K; Masuda J; Hamasaki K; Yatsuhashi H; Nakao K
    Med Sci Monit; 2013 Sep; 19():742-50. PubMed ID: 24008520
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Perspectives on using des-γ-carboxyprothrombin (DCP) as a serum biomarker: facilitating early detection of hepatocellular carcinoma in China.
    Song P; Feng X; Zhang K; Song T; Ma K; Kokudo N; Dong J; Tang W
    Hepatobiliary Surg Nutr; 2013 Aug; 2(4):227-31. PubMed ID: 24570947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alpha-Fetoprotein, Des-Gamma-Carboxy Prothrombin, and Modified RECIST Response as Predictors of Survival after Transarterial Radioembolization for Hepatocellular Carcinoma.
    Lim TS; Rhee H; Kim GM; Kim SU; Kim BK; Park JY; Ahn SH; Han KH; Choi JY; Kim DY
    J Vasc Interv Radiol; 2019 Aug; 30(8):1194-1200.e1. PubMed ID: 31235408
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study.
    Cabibbo G; Maida M; Genco C; Parisi P; Peralta M; Antonucci M; Brancatelli G; Cammà C; Craxì A; Di Marco V
    World J Hepatol; 2012 Sep; 4(9):256-61. PubMed ID: 23060970
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Diagnostic Value of Abnormal Prothrombin in HBV-related AFP-negative Hepatocellular Carcinoma].
    Wei RR; Wang CC; Li DJ; Hu XY; Liu K
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):411-415. PubMed ID: 32543152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical significance of half-lives of tumor markers α-fetoprotein and des-γ-carboxy prothrombin after hepatectomy for hepatocellular carcinoma.
    Tsukamoto M; Nitta H; Imai K; Higashi T; Nakagawa S; Okabe H; Arima K; Kaida T; Taki K; Hashimoto D; Chikamoto A; Ishiko T; Beppu T; Baba H
    Hepatol Res; 2018 Feb; 48(3):E183-E193. PubMed ID: 28796412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of serum AFP and DCP levels in the diagnosis of early-stage HBV-related HCC under different backgrounds.
    Song T; Wang L; Xin R; Zhang L; Tian Y
    J Int Med Res; 2020 Oct; 48(10):300060520969087. PubMed ID: 33135527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
    Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
    World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol.
    Huang TS; Shyu YC; Turner R; Chen HY; Chen PJ
    Syst Rev; 2013 Jun; 2():37. PubMed ID: 23738605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction of Prognosis of Intermediate-Stage HCC Patients: Validation of the Tumor Marker Score in a Nationwide Database in Japan.
    Hiraoka A; Michitaka K; Kumada T; Izumi N; Kadoya M; Kokudo N; Kubo S; Matsuyama Y; Nakashima O; Sakamoto M; Takayama T; Kokudo T; Kashiwabara K; Eguchi S; Yamashita T; Kudo M
    Liver Cancer; 2019 Oct; 8(5):403-411. PubMed ID: 31768348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Study on the value of serum des-γ-carboxy prothrombin in predicting hepatocellular carcinoma recurrence after liver transplantation].
    Xu Y; Wang PX; Cheng JW; Huang XW; Zhou J; Fan J; Yang XR
    Zhonghua Gan Zang Bing Za Zhi; 2020 Nov; 28(11):918-923. PubMed ID: 33256276
    [No Abstract]   [Full Text] [Related]  

  • 56. Studies on the correlation among the fucosylation index, concentration of alpha-fetoprotein and des-gamma-carboxy prothrombin as prognostic indicators in hepatocellular carcinoma.
    Igarashi H; Aoyagi Y; Suda T; Mita Y; Kawai K
    Hepatol Res; 2003 Dec; 27(4):280-288. PubMed ID: 14662116
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rapid and early α-fetoprotein and des-γ-carboxy prothrombin responses to initial arterial infusion chemotherapy predict treatment outcomes of advanced hepatocellular carcinoma.
    Oyama K; Koda M; Sugihara T; Kishina M; Miyoshi K; Okamoto T; Hodotsuka M; Fujise Y; Matono T; Tokunaga S; Okamoto K; Hosho K; Okano J; Murawaki Y
    Mol Clin Oncol; 2015 May; 3(3):655-662. PubMed ID: 26137283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Highly sensitive alpha-fetoprotein, Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxyprothrombin for hepatocellular carcinoma detection.
    Caviglia GP; Abate ML; Petrini E; Gaia S; Rizzetto M; Smedile A
    Hepatol Res; 2016 Mar; 46(3):E130-5. PubMed ID: 26082262
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma.
    Lok AS; Sterling RK; Everhart JE; Wright EC; Hoefs JC; Di Bisceglie AM; Morgan TR; Kim HY; Lee WM; Bonkovsky HL; Dienstag JL;
    Gastroenterology; 2010 Feb; 138(2):493-502. PubMed ID: 19852963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical utility of simultaneous measurement of alpha-fetoprotein and des-γ-carboxy prothrombin for diagnosis of patients with hepatocellular carcinoma in China: A multi-center case-controlled study of 1,153 subjects.
    Song P; Feng X; Inagaki Y; Song T; Zhang K; Wang Z; Zheng S; Ma K; Li Q; Kong D; Wu Q; Zhang T; Zhao X; Hasegawa K; Sugawara Y; Kokudo N; Tang W;
    Biosci Trends; 2014 Oct; 8(5):266-73. PubMed ID: 25382443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.